A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer

被引：2
|
作者：
Kasi, P. M. [1 ]
Sawyer, S. [2 ]
Guilford, J. [2 ]
Munro, M. [2 ]
Ellers, S. [2 ]
Hook, N. [2 ]
Krinshpun, S. [2 ]
Moshkevich, S. [2 ]
Billings, P. R. [2 ]
Aleshin, A. [2 ]
机构：
[1] Univ Iowa Hlth Care, Internal Med, Iowa City, IA USA
[2] Natera Inc, Oncol, San Carlos, CA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
520TiP
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [41] Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
    Yoshiko Kitazume
    Hitoshi Kawazoe
    Ryuji Uozumi
    Tomoe Yoshizawa
    Hirotoshi Iihara
    Hironori Fujii
    Masaya Takahashi
    Takahiro Arai
    Yasushi Murachi
    Yumiko Sato
    Takahiro Mikami
    Koji Hashiguchi
    Tomoko Yamazaki
    Katsuyuki Takahashi
    Yukiyoshi Fujita
    Yuki Hosokawa
    Issei Morozumi
    Masami Tsuchiya
    Atsushi Yokoyama
    Hironobu Hashimoto
    Masakazu Yamaguchi
    Scientific Reports, 12
  • [42] Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma
    Brunsgaard, Elise K.
    Bowles, Tawnya L.
    Asare, Elliot A.
    Grossmann, Kenneth
    Boucher, Kenneth M.
    Grossmann, Allie
    Jackson, Julie A.
    Wada, David A.
    Rathore, Richa
    Budde, Griffin
    Grandemange, Andrew
    Hyngstrom, John R.
    MELANOMA RESEARCH, 2023, 33 (03) : 184 - 191
  • [43] Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)
    Musher, Benjamin L.
    Melson, Joshua E.
    Amato, Gianni
    Chan, David
    Hill, Marisa
    Khan, Iftekhar
    Kochuparambil, Samith T.
    Lyons, Susan E.
    Orsini, James, Jr.
    Pedersen, Susanne K.
    Robb, Bruce
    Saltzman, Joel
    Silinsky, Jennifer
    Gaur, Snigdha
    Tuck, Melissa K.
    LaPointe, Lawrence C.
    Young, Graeme P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (12) : 2702 - 2709
  • [44] Role of circulating tumor DNA in the management of patients with colorectal cancer
    Moati, Emilie
    Taly, Valerie
    Didelot, Audrey
    Perkins, Geraldine
    Blons, Helene
    Taieb, Julien
    Laurent-Puig, Pierre
    Zaanan, Aziz
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (05) : 396 - 402
  • [45] Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).
    Diehn, Maximilian
    Alizadeh, Ash A.
    Adams, Hans-Peter
    Lee, John J.
    Klassen, Susanne
    Palma, John F.
    Hinzman, Bernd
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Yao, Lijing
    Yaung, Stephanie
    Balasubramanyam, Aarthi
    Rohr, Ulrich Peter
    Rosenthal, Andre
    Kube, Rainer
    Steinmueller, Thomas
    Marusch, Frank
    Mantke, Rene
    Heise, Michael
    Pross, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients
    Frydendahl, Amanda
    Nors, Jesper
    Rasmussen, Mads H.
    Henriksen, Tenna V.
    Nesic, Marijana
    Reinert, Thomas
    Afterman, Danielle
    Lauterman, Tomer
    Kuzman, Maja
    Gonzalez, Santiago
    Glavas, Dunja
    Smadback, James
    Maloney, Dillon
    Levativ, Jurica
    Yahalom, Michael
    Ptashkin, Ryan
    Tavassoly, Iman
    Donenhirsh, Zohar
    White, Eric
    Kandasamy, Ravi
    Alon, Ury
    Nordentoft, Iver
    Lindskrog, Sia V.
    Dyrskjot, Lars
    Jaensch, Claudia
    Love, Uffe S.
    Andersen, Per V.
    Thorlacius-Ussing, Ole
    Iversen, Lene H.
    Gotschalck, Kare A.
    Zviran, Asaf
    Oklander, Boris
    Andersen, Claus L.
    EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [47] Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
    Jalaeikhoo, Hasan
    Zokaasadi, Mohammad
    Khajeh-Mehrizi, Ahmad
    Rajaeinejad, Mohsen
    Mousavi, Seied Asadollah
    Vaezi, Mohammad
    Fumani, Hosein Kmranzadeh
    Keyhani, Manoutchehr
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24
  • [48] RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
    Bachet, J. B.
    Bouche, O.
    Taieb, J.
    Dubreuil, O.
    Garcia, M. L.
    Meurisse, A.
    Normand, C.
    Gornet, J. M.
    Artru, P.
    Louafi, S.
    Bonnetain, F.
    Thirot-Bidault, A.
    Baumgaertner, I
    Coriat, R.
    Tougeron, D.
    Lecomte, T.
    Mary, F.
    Aparicio, T.
    Marthey, L.
    Taly, V
    Blons, H.
    Vernerey, D.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1211 - 1219
  • [49] DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection.
    Lee, Rebecca
    Rothwell, Dominic G.
    Jackson, Richard
    Smith, Nigel
    Wong, Stephen Q.
    Kelso, Noel
    Burghel, George
    Hewitt, Chelsee
    Clarke, Harry
    Mitchell, Jackie
    Jones, Kate
    Muinonen-Martin, Andrew
    Turajlic, Samra
    Corrie, Philippa Gail
    Marais, Richard
    Middleton, Mark R.
    Dawson, Sarah-Jane
    Sandhu, Shahneen
    Dive, Caroline
    Lorigan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study
    Rhodin, Kristen E.
    O'Connor, Margaret H.
    Therien, Aaron
    Hollander, Shayna
    Geron, Viviana
    Nair, Uma
    Rakestraw, Emily
    Salama, April K.
    Shah, Riddhishkumar
    Tyler, Douglas S.
    Beasley, Georgia M.
    ANNALS OF SURGICAL ONCOLOGY, 2025,
12345